Pharmaserv Logistics Creates a "Central Pharmaceutical Distribution Center"

Pharmaserv Logistics Central Pharmaceutical Distribution Centre currently under...
Pharmaserv Logistics' "Central Pharmaceutical Distribution Centre" currently under construction

Pharmaserv Logistics, the contract logistics service provider specializing in the pharmaceutical and biotech sectors, is expanding its existing GMP warehouse capacity at its Behringwerke site in Marburg, Germany.

A further new extension will complete the expansion to create a "Central Pharmaceutical Distribution Centre" by late 2015. From 2016 onwards, additional new customers in the pharmaceutical, biotech and medical care sectors will be serviced from there. Different temperature ranges are now available to customers for the storage, handling and distribution of pharmaceutical productions – naturally all GMP and GDP-compliant.

Pharmaserv Logistics' new build enables the service provider to meet the rising demand for specialist logistics services for sensitive and temperature-controlled drugs. The central distribution center concept also efficiently supports international pharmaceutical customers in their efforts to penetrate and supply the European market.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.